HOWL FY 2021 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$41M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$50M

Net Income

-$50M

EPS (Diluted)

$-10.94

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$43M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$179M

Total Liabilities

$26M

Stockholders' Equity

$153M

Cash & Equivalents

$158M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$777,000	+100.0%
Operating Income	-$50M	-$22M	-123.6%
Net Income	-$50M	-$15M	-234.6%